Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Docetaxel/telatinib combination shows promise in cancer patients

Nov. 14, 2007

VioQuest cancer agents progress through early studies

Nov. 14, 2007

AVEO reports positive results from phase I clinical trial of AV-951

Nov. 13, 2007

Synta initiates phase I clinical study of novel Hsp90 inhibitor STA-9090

Nov. 13, 2007

Preclinical studies support investigation of AT-101 in lung cancer

Nov. 13, 2007

Intratumoral TNFerade injection feasible in rectal cancer patients

Nov. 13, 2007

Phase I and II studies of belinostat presented at AACR-NCI-EORTC congress

Nov. 13, 2007

FDA approves IND application for Metastatix's CXCR4 inhibitor MSX-122

Nov. 12, 2007

First patient undergoes StemEx transplant in ExCell registration study

Nov. 12, 2007

Anticancer activity seen with ARQ-197 in phase I metastatic cancer trial

Nov. 12, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...